MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions
View by Date

Tuesday, June 21, 2016

12:30pm-2:00pm
A pilot study of SD-809 (deutetrabenazine) in tics associated with Tourette syndrome

J. Jankovic, J. Jimenez-Shahed, C. Budman, B. Coffey, T.K. Murphy, D. Shprecher, D. Stamler (Houston, TX, USA)

Tics/Stereotypies  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
A pilot study of whole exome sequencing in progressive supranuclear palsy

K.Y. Mok, A. Tucci, R. de Silva, H.R. Morris, A.B. Singleton, H. Houlden, J. Hardy, IPDGC (London, United Kingdom)

Genetics (NON-PD)  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
A randomized, double-blind, placebo-controlled trial of deutetrabenazine for the treatment of tardive dyskinesia (ARM-TD)

H.H. Fernandez, S.A. Factor, R.A. Hauser, J. Jimenez-Shahed, W. Ondo, M.S. LeDoux, D. Shprecher, T. Simuni, D. Stamler, K.E. Anderson (Cleveland, OH, USA)

Drug-induced movement disorders  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
A rare genetic transcriptomopathy syndrome involving TAF1 leading to insights into more common neurologic disorders, including X-linked dystonia-parkinsonism (XDP)

G.J. Lyon (New York, NY, USA)

Genetics (NON-PD)  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
A strategy to classify Parkinson’s disease patients with dyskinesia: The analysis of center of pressure with impact of cognitive loading

W. Buated, P. Lolekha, T. Fujinami, S. Hidaka (Nomi, Japan)

Technology  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
A survey of movement disorders in a large sample of patients treated with antipsychotic medication

B. Balint, H. Killaspy, T.R.E. Barnes, N. Freemantle, E. Joyce, D. Martino, K.P. Bhatia (London, United Kingdom)

Drug-induced movement disorders  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
A validation study of a smartphone-based finger tapping application for quantitative assessment of bradykinesia in Parkinson’s disease

C.Y. Lee, S.J. Kang, Y.E. Kim, U. Lee, H.I. Ma, Y.J. Kim (Anyang-si, Gyeonggi-do, Korea)

Technology  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
A web resource on levodopa-induced dyskinesia (LID) genetics

M. Falla, H. Blankenburg, P. Gruber, I. Pichler, C. Schwienbacher, A. Hicks, F. Domingues, P.P. Pramstaller (Bolzano/Bozen, Italy)

Parkinson's disease: Genetics  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
A whole brain anatomical network model and its application in PD research

X. Lei, T. Chen, X. Hu, B. Zhang (Kunming, People's Republic of China)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Age associated effects of levodopa administration on striatal acetylcholinesterase activity

M. Messripour, A. Mesripour (Isfahan, Islamic Republic of Iran)

Drug-induced movement disorders  ·  Exhibit Hall located in Hall B, Level 2
  • «Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 48
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Movement disorders in chronic obstructive pulmonary disease (COPD); the effect of pulmonary disease to brain
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley